98 related articles for article (PubMed ID: 10373633)
21. [Effects of inhibited IGF-IR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines].
Yao NH; Yao DF; Dong ZZ; Yan XD; Chen J; Yao M; Wang L; Yan MJ
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):376-80. PubMed ID: 24025141
[TBL] [Abstract][Full Text] [Related]
22. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ
Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
24. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
[TBL] [Abstract][Full Text] [Related]
25. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
26. Antineoplastic mechanism of Octreotide action in human hepatoma.
Chen X; Liu Z; Ai Z
Chin Med J (Engl); 2001 Nov; 114(11):1167-70. PubMed ID: 11729512
[TBL] [Abstract][Full Text] [Related]
27. Ponicidin inhibits cell growth on hepatocellular carcinoma cells by induction of apoptosis.
Zhang JF; Liu PQ; Chen GH; Lu MQ; Cai CJ; Yang Y; Li H
Dig Liver Dis; 2007 Feb; 39(2):160-6. PubMed ID: 17049940
[TBL] [Abstract][Full Text] [Related]
28. Allyl-isatin suppresses cell viability, induces cell cycle arrest, and promotes cell apoptosis in hepatocellular carcinoma HepG2 cells.
Bian W; An Y; Qu H; Yang Y; Yang J; Xu Y
Fundam Clin Pharmacol; 2016 Jun; 30(3):253-62. PubMed ID: 26945926
[TBL] [Abstract][Full Text] [Related]
29. The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis.
Wang F; He Z; Dai W; Li Q; Liu X; Zhang Z; Zhai D; Chen J; Chen W
J Cancer Res Ther; 2015; 11(3):597-605. PubMed ID: 26458588
[TBL] [Abstract][Full Text] [Related]
30. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines.
Cuestas ML; Sosnik A; Mathet VL
Mol Pharm; 2011 Aug; 8(4):1152-64. PubMed ID: 21591727
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells.
Wu LF; Li GP; Feng JL; Pu ZJ
Acta Pharmacol Sin; 2006 Apr; 27(4):477-84. PubMed ID: 16539849
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
33. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
34. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis of Hepatocellular Carcinoma Cells Induced by Nanoencapsulated Polysaccharides Extracted from Antrodia Camphorata.
Chang JS; Kuo HP; Chang KL; Kong ZL
PLoS One; 2015; 10(9):e0136782. PubMed ID: 26327534
[TBL] [Abstract][Full Text] [Related]
36. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
[TBL] [Abstract][Full Text] [Related]
37. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract][Full Text] [Related]
38. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
[TBL] [Abstract][Full Text] [Related]
39. Induction of Human Hepatocellular Carcinoma HepG2 Cell Apoptosis by Naringin.
Banjerdpongchai R; Wudtiwai B; Khawon P
Asian Pac J Cancer Prev; 2016; 17(7):3289-94. PubMed ID: 27509965
[TBL] [Abstract][Full Text] [Related]
40. CAPE promotes TRAIL-induced apoptosis through the upregulation of TRAIL receptors via activation of p38 and suppression of JNK in SK-Hep1 hepatocellular carcinoma cells.
Kim EY; Ryu JH; Kim AK
Int J Oncol; 2013 Oct; 43(4):1291-300. PubMed ID: 23857473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
